269 related articles for article (PubMed ID: 36315446)
1. Comprehensive analysis of prognostic significance of cadherin (CDH) gene family in breast cancer.
Ku SC; Liu HL; Su CY; Yeh IJ; Yen MC; Anuraga G; Ta HDK; Chiao CC; Xuan DTM; Prayugo FB; Wang WJ; Wang CY
Aging (Albany NY); 2022 Oct; 14(20):8498-8567. PubMed ID: 36315446
[TBL] [Abstract][Full Text] [Related]
2. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase inhibitor entinostat reverses epithelial to mesenchymal transition of breast cancer cells by reversing the repression of E-cadherin.
Shah P; Gau Y; Sabnis G
Breast Cancer Res Treat; 2014 Jan; 143(1):99-111. PubMed ID: 24305977
[TBL] [Abstract][Full Text] [Related]
4. Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells.
Castillo LF; Tascón R; Lago Huvelle MR; Novack G; Llorens MC; Dos Santos AF; Shortrede J; Cabanillas AM; Bal de Kier Joffé E; Labriola L; Peters MG
Oncotarget; 2016 Sep; 7(37):60133-60154. PubMed ID: 27507057
[TBL] [Abstract][Full Text] [Related]
5. Restoration of E-cadherin expression by selective Cox-2 inhibition and the clinical relevance of the epithelial-to-mesenchymal transition in head and neck squamous cell carcinoma.
Fujii R; Imanishi Y; Shibata K; Sakai N; Sakamoto K; Shigetomi S; Habu N; Otsuka K; Sato Y; Watanabe Y; Ozawa H; Tomita T; Kameyama K; Fujii M; Ogawa K
J Exp Clin Cancer Res; 2014 May; 33(1):40. PubMed ID: 24887090
[TBL] [Abstract][Full Text] [Related]
6. The Cdc42/Rac1 regulator CdGAP is a novel E-cadherin transcriptional co-repressor with Zeb2 in breast cancer.
He Y; Northey JJ; Pelletier A; Kos Z; Meunier L; Haibe-Kains B; Mes-Masson AM; Côté JF; Siegel PM; Lamarche-Vane N
Oncogene; 2017 Jun; 36(24):3490-3503. PubMed ID: 28135249
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of epithelial to mesenchymal transition by E-cadherin up-regulation via repression of slug transcription and inhibition of E-cadherin degradation: dual role of scaffold/matrix attachment region-binding protein 1 (SMAR1) in breast cancer cells.
Adhikary A; Chakraborty S; Mazumdar M; Ghosh S; Mukherjee S; Manna A; Mohanty S; Nakka KK; Joshi S; De A; Chattopadhyay S; Sa G; Das T
J Biol Chem; 2014 Sep; 289(37):25431-44. PubMed ID: 25086032
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic silencing of genes enhanced by collective role of reactive oxygen species and MAPK signaling downstream ERK/Snail axis: Ectopic application of hydrogen peroxide repress CDH1 gene by enhanced DNA methyltransferase activity in human breast cancer.
Pradhan N; Parbin S; Kar S; Das L; Kirtana R; Suma Seshadri G; Sengupta D; Deb M; Kausar C; Patra SK
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1651-1665. PubMed ID: 30954555
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the first microRNA in human CDH1 that affects cell cycle and apoptosis and indicates breast cancers progression.
Gharbi S; Mohammadi Z; Dezaki MS; Dokanehiifard S; Dabiri S; Korsching E
J Cell Biochem; 2022 Mar; 123(3):657-672. PubMed ID: 34997630
[TBL] [Abstract][Full Text] [Related]
10. Over-Expressed Twist Associates with Markers of Epithelial Mesenchymal Transition and Predicts Poor Prognosis in Breast Cancers via ERK and Akt Activation.
Zhang YQ; Wei XL; Liang YK; Chen WL; Zhang F; Bai JW; Qiu SQ; Du CW; Huang WH; Zhang GJ
PLoS One; 2015; 10(8):e0135851. PubMed ID: 26295469
[TBL] [Abstract][Full Text] [Related]
11. Notch3 Transactivates Glycogen Synthase Kinase-3-Beta and Inhibits Epithelial-to-Mesenchymal Transition in Breast Cancer Cells.
Chen W; Zhang Y; Li R; Huang W; Wei X; Zeng D; Liang Y; Zeng Y; Chen M; Zhang L; Gao W; Zhu Y; Li Y; Zhang G
Cells; 2022 Sep; 11(18):. PubMed ID: 36139447
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-372-3p promotes the epithelial-mesenchymal transition in breast carcinoma by activating the Wnt pathway.
Fan X; Huang X; Li Z; Ma X
J BUON; 2018; 23(5):1309-1315. PubMed ID: 30570852
[TBL] [Abstract][Full Text] [Related]
13. Carbohydrate (Chondroitin 4) Sulfotransferase-11-Mediated Induction of Epithelial-Mesenchymal Transition and Generation of Cancer Stem Cells.
Behrens A; Jousheghany F; Yao-Borengasser A; Siegel ER; Kieber-Emmons T; Monzavi-Karbassi B
Pharmacology; 2020; 105(5-6):246-259. PubMed ID: 32344408
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of FOXC1 Promotes Tumor Metastasis by Activating the Wnt/β-Catenin Signaling Pathway in Gastric Cancer.
Sun Y; Lin C; Ding Q; Dai Y
Dig Dis Sci; 2022 Aug; 67(8):3742-3752. PubMed ID: 34427817
[TBL] [Abstract][Full Text] [Related]
15. Foxf2 plays a dual role during transforming growth factor beta-induced epithelial to mesenchymal transition by promoting apoptosis yet enabling cell junction dissolution and migration.
Meyer-Schaller N; Heck C; Tiede S; Yilmaz M; Christofori G
Breast Cancer Res; 2018 Oct; 20(1):118. PubMed ID: 30285803
[TBL] [Abstract][Full Text] [Related]
16. Long Noncoding RNA TCONS_00068220 Promotes Breast Cancer Progression by Regulating Epithelial-Mesenchymal Transition Marker E-Cadherin.
Liu X; Tian X
Med Sci Monit; 2021 Mar; 27():e929832. PubMed ID: 33716295
[TBL] [Abstract][Full Text] [Related]
17. N-Cadherin mRNA Levels in Peripheral Blood Could Be a Potential Indicator of New Metastases in Breast Cancer: A Pilot Study.
Masuda T; Ueo H; Kai Y; Noda M; Hu Q; Sato K; Fujii A; Hayashi N; Tsuruda Y; Otsu H; Kuroda Y; Eguchi H; Ohno S; Mimori K; Ueo H
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31947504
[TBL] [Abstract][Full Text] [Related]
18. SREBP1, targeted by miR-18a-5p, modulates epithelial-mesenchymal transition in breast cancer via forming a co-repressor complex with Snail and HDAC1/2.
Zhang N; Zhang H; Liu Y; Su P; Zhang J; Wang X; Sun M; Chen B; Zhao W; Wang L; Wang H; Moran MS; Haffty BG; Yang Q
Cell Death Differ; 2019 May; 26(5):843-859. PubMed ID: 29988076
[TBL] [Abstract][Full Text] [Related]
19. Systemic analysis of the expression levels and prognosis of breast cancer-related cadherins.
Xu M; Liu C; Pu L; Lai J; Li J; Ning Q; Liu X; Deng S
Exp Biol Med (Maywood); 2021 Aug; 246(15):1706-1720. PubMed ID: 33899544
[TBL] [Abstract][Full Text] [Related]
20. Integrin alpha-2 and beta-1 expression increases through multiple generations of the EDW01 patient-derived xenograft model of breast cancer-insight into their role in epithelial mesenchymal transition in vivo gained from an in vitro model system.
Wafai R; Williams ED; de Souza E; Simpson PT; McCart Reed AE; Kutasovic JR; Waltham M; Snell CE; Blick T; Thompson EW; Hugo HJ
Breast Cancer Res; 2020 Dec; 22(1):136. PubMed ID: 33276802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
